Elevance Health Inc (ELV)vsMorgan Stanley (MS)
ELV
Elevance Health Inc
$415.53
-0.71%
HEALTHCARE · Cap: $87.28B
MS
Morgan Stanley
$211.93
-0.80%
FINANCIAL SERVICES · Cap: $343.82B
Smart Verdict
WallStSmart Research — data-driven comparison
Elevance Health Inc generates 174% more annual revenue ($200.42B vs $73.17B). MS leads profitability with a 24.7% profit margin vs 2.6%. ELV appears more attractively valued with a PEG of 1.47. MS earns a higher WallStSmart Score of 71/100 (B).
ELV
Buy56
out of 100
Grade: C
MS
Strong Buy71
out of 100
Grade: B
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+4.5%
Fair Value
$416.35
Current Price
$415.53
$0.82 discount
Intrinsic value data unavailable for MS.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Attractively priced relative to earnings
Reasonable price relative to book value
Generating 4.1B in free cash flow
Mega-cap, among the largest globally
Strong operational efficiency at 40.6%
Keeps 25 of every $100 in revenue as profit
16.3% revenue growth
Earnings expanding 31.9% YoY
Areas to Watch
2.6% revenue growth
2.6% margin — thin
Earnings declined 16.8%
Expensive relative to growth rate
Negative free cash flow — burning cash
Distress zone — elevated risk
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : ELV
The strongest argument for ELV centers on Market Cap, P/E Ratio, Price/Book. PEG of 1.47 suggests the stock is reasonably priced for its growth.
Bull Case : MS
The strongest argument for MS centers on Market Cap, Operating Margin, Profit Margin. Profitability is solid with margins at 24.7% and operating margin at 40.6%. Revenue growth of 16.3% demonstrates continued momentum.
Bear Case : ELV
The primary concerns for ELV are Revenue Growth, Profit Margin, EPS Growth. Thin 2.6% margins leave little buffer for downturns.
Bear Case : MS
The primary concerns for MS are PEG Ratio, Free Cash Flow, Altman Z-Score. Debt-to-equity of 3.45 is elevated, increasing financial risk.
Key Dynamics to Monitor
ELV profiles as a value stock while MS is a growth play — different risk/reward profiles.
MS carries more volatility with a beta of 1.22 — expect wider price swings.
MS is growing revenue faster at 16.3% — sustainability is the question.
ELV generates stronger free cash flow (4.1B), providing more financial flexibility.
Bottom Line
MS scores higher overall (71/100 vs 56/100), backed by strong 24.7% margins and 16.3% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Elevance Health Inc
HEALTHCARE · HEALTHCARE PLANS · USA
Elevance Health Inc. is a health benefits company. The company is headquartered in Indianapolis, Indiana.
Morgan Stanley
FINANCIAL SERVICES · CAPITAL MARKETS · USA
Morgan Stanley is an American multinational investment bank and financial services company headquartered at 1585 Broadway in the Morgan Stanley Building, Midtown Manhattan, New York City.
Compare with Other HEALTHCARE PLANS Stocks
Want to dig deeper into these stocks?